国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli Inner membrane transport protein ydiN (ydiN), partial CSB-YP303486ENV
CSB-EP303486ENV
CSB-BP303486ENV
CSB-MP303486ENV
CSB-EP303486ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yniB (yniB), partial CSB-YP303487ENV1
CSB-EP303487ENV1
CSB-BP303487ENV1
CSB-MP303487ENV1
CSB-EP303487ENV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein ydjY (ydjY) CSB-YP303488ENV
CSB-EP303488ENV
CSB-BP303488ENV
CSB-MP303488ENV
CSB-EP303488ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Inner membrane protein ynjI (ynjI), partial CSB-YP303489ENV1
CSB-EP303489ENV1
CSB-BP303489ENV1
CSB-MP303489ENV1
CSB-EP303489ENV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yoaI (yoaI), partial CSB-YP303490ENV
CSB-EP303490ENV
CSB-BP303490ENV
CSB-MP303490ENV
CSB-EP303490ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Leucine efflux protein (leuE), partial CSB-YP303491ENV1
CSB-EP303491ENV1
CSB-BP303491ENV1
CSB-MP303491ENV1
CSB-EP303491ENV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Transcriptional regulator kdgR (kdgR) CSB-YP303492ENV
CSB-EP303492ENV
CSB-BP303492ENV
CSB-MP303492ENV
CSB-EP303492ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yobB (yobB) CSB-YP303493ENV
CSB-EP303493ENV
CSB-BP303493ENV
CSB-MP303493ENV
CSB-EP303493ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Flagellar biosynthesis protein flhA (flhA), partial CSB-YP303494ENV
CSB-EP303494ENV
CSB-BP303494ENV
CSB-MP303494ENV
CSB-EP303494ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yedM (yedM) CSB-YP303495ENV
CSB-EP303495ENV
CSB-BP303495ENV
CSB-MP303495ENV
CSB-EP303495ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable transcriptional regulatory protein YedW (yedW) CSB-YP303496ENV
CSB-EP303496ENV
CSB-BP303496ENV
CSB-MP303496ENV
CSB-EP303496ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative uncharacterized protein yeeL (yeeL) CSB-YP303497ENV
CSB-EP303497ENV
CSB-BP303497ENV
CSB-MP303497ENV
CSB-EP303497ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative uncharacterized protein yeeP (yeeP) CSB-YP303498ENV
CSB-EP303498ENV
CSB-BP303498ENV
CSB-MP303498ENV
CSB-EP303498ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Tyrosine-protein kinase wzc (wzc), partial CSB-YP303499ENV1
CSB-EP303499ENV1
CSB-BP303499ENV1
CSB-MP303499ENV1
CSB-EP303499ENV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protease yegQ (yegQ) CSB-YP303500ENV
CSB-EP303500ENV
CSB-BP303500ENV
CSB-MP303500ENV
CSB-EP303500ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yegX (yegX) CSB-YP303501ENV
CSB-EP303501ENV
CSB-BP303501ENV
CSB-MP303501ENV
CSB-EP303501ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Inner membrane protein yeiU (yeiU), partial CSB-YP303502ENV1
CSB-EP303502ENV1
CSB-BP303502ENV1
CSB-MP303502ENV1
CSB-EP303502ENV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yfaP (yfaP) CSB-YP303503ENV
CSB-EP303503ENV
CSB-BP303503ENV
CSB-MP303503ENV
CSB-EP303503ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable 4-deoxy-4-formamido-L-arabinose-phosphoundecaprenol deformylase ArnD (arnD) CSB-YP303504ENV
CSB-EP303504ENV
CSB-BP303504ENV
CSB-MP303504ENV
CSB-EP303504ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yfbO (yfbO) CSB-YP303505ENV
CSB-EP303505ENV
CSB-BP303505ENV
CSB-MP303505ENV
CSB-EP303505ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>